Position in PTGX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$21,837,870
-$31,716,184 QoQ
Shares Held
178,152
-64.9% QoQ
Ownership
0.275%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 343 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 80%
Shared 14%
None 5%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. PTGX ranks #56 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in PTGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,837,870 | 178,152 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $53,554,054 | 508,103 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $36,195,005 | 414,415 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $29,130,549 | 438,515 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,951,362 | 180,050 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,878,351 | 121,554 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $8,708,160 | 225,600 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,151,505 | 225,589 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $21,350,358 | 616,172 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $22,893,581 | 791,344 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $18,723,192 | 816,537 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $15,700,448 | 941,274 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $28,700,078 | 1,039,105 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $29,031,957 | 1,262,259 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $11,752,534 | 1,077,226 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $6,916,291 | 820,438 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,745,448 | 852,775 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $20,433,282 | 862,892 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $29,913,064 | 874,651 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $15,517,971 | 875,732 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $35,500,798 | 791,016 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $16,993,015 | 656,101 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $13,094,726 | 649,540 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $13,396,754 | 685,256 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $12,130,601 | 686,897 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $4,755,954 | 673,648 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||